Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The objective of this study is to compare the relative bioavailability of fluoxetine HCL 40 mg capsules (by Ranbaxy Laboratories Limited) with that of PROZAC® 40 mg capsules (by Dista Products Company) following a single oral dose (1 x 40 mg capsule) in healthy, adult subjects under fasting conditions
Epistemonikos ID: 9be90c547b4ee61d48c230b6ec11441751f9ae5e
First added on: May 05, 2024